References
- Bensinger W. I., Buckner C. D., Thomas E. D., Clift R. A. ABO-incompatible marrow transplants. Transplantation 1982; 33: 427–429
- Sniecinski I. J., Petz L. D., Oien L., Blume K. G. Immunohematologic problems arising from ABO incompatible bone marrow transplantation. Transplantation 1987; XIX: 4609–-4611
- Braine H. G., Sensenbrenner L. L., Wright S. K., Tutschka P. J., Saral R., Santos G. W. Bone marrow transplantation with major Blood ABO Blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 1982; 60: 420–425
- Blacklock H. A., Prentice H. G., Evans J. P. M., Knight C. B. T., Gilmore M. J. M. L., Hazlehurst G. R. P., Ma D. D. F., Hoffbrand A. V. ABO-incompatible bone marrow transplantation: Removal of red Blood cells from donor marrow avoiding recipient antibody depletion. Lancet 1982; ii: 1061–-1064
- Marmont A. M., Frassoni F., Van Lint M. T., Podesta M., Lardan G., Occhini D., Piaggio G., Bachigalupo A. Isohemagglutinin induced pure red cell aplasia following major ABO incompatible marrow transplant for severe aplastic anemia. Resolution after plasma exchange. Experimental Hematology 1983; 11: 51–53, (Suppl 13)
- Sniecinski I. J., Oien L., Petz L. D., Blume K. G. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45: 530–534
- Barge A. J., Johnson G., Witherspoon R., Torok-Storb B. Antibody-mediated bone marrow failure after allogeneic bone marrow transplantation. Blood 1989; 74: 1477–1480
- Gmüir J. P., Burger J., Schaffner A., Neftel K., Oelz O., Frey D., Metaxas M. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290–295
- Messner H. A., Fauser A. A., Curtis J. E., Dotten D. Control of antibody-mediated pure red-cell aplasia by plamapheresis. New England Journal of Medicine 1981; 22: 1334–1338
- Sieff C., Bicknell D., Caine G., Robinson J., Lam G., Greaves M. F. Changes in cell surface antigen expression during hemopoietic differentiation. Blood 1982; 60: 703–713
- Yam P. Y., Petz L. D., Knowlton R. G., Wallace R. B., Stock A. D., de Lange G., Brown V. A., Donis-Keller H., Blume K. G. Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 1987; 43: 399–407
- Hanada T., Abe T., Nakamura H., Aoki Y. Pure red cell aplasia: relationship between inhibitory activity of T cells to CFU-E and erythropoiesis. British Journal of Haemato-logy 1984; 58: 107–113
- Mangan K. F., Shadduck R. K. Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: Correlation with in vitro erythroid culture studies. American Journal of Hematology 1984; 17: 417–426
- Chikkappa G., Zarrabi M. H., Min-Fu T. Pure red cell aplasia in patients with chronic lymphocytic leukemia. Medicine 1986; 65: 339–351
- Mangan K. F., D'Alessandro L. Hypoplastic anemia in B cell chronic lymphocytic leukemia: Evolution of T cell-mediated suppression of erythropoiesis in early-stage and late-stage disease. Blood 1985; 66: 533–541
- Abkowitz J. L., Powell J. S., Nakamura J. M., Kadin M. E., Adamson J. W. Pure red cell aplasia: Response to therapy with anti-thymocyte globulin. American Journal of Hematology 1986; 23: 363–371
- Bandini G., Michallet M., Rosti G., Tura S. Bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplantation 1991; 7: 251–253